Concepedia

Marjo Kela

MK

Statistics

Publications

3

Citations

108

H-Index

3

Active since

2002

Affiliations

Orion Corporation (Finland)(Current)

Helsinki University Hospital

Orion Corporation (United Kingdom)

Marjo Kela is an author at Orion Corporation (Finland) specializing in pharmacokinetics, pharmacology, and movement disorder pharmacotherapy.

Publications per year

2002–2004

3

Publications

3

Entacapone improves the availability of <scp>l</scp>‐dopa in plasma by decreasing its peripheral metabolism independent of <scp>l</scp>‐dopa/carbidopa dose

Helena Heikkinen, Anu Varhe, Tarmo Laine et al. · British Journal of Clinical Pharmacology · 2002 · 56 citations · Full text

, , +17

Equivalent lung deposition of budesonide <i>in vivo</i>: a comparison of dry powder inhalers using a pharmacokinetic method

Satu Lähelmä, Merja Kirjavainen, Marjo Kela et al. · British Journal of Clinical Pharmacology · 2004 · 37 citations · Full text

, , +17

Pharmacokinetics of estradiol valerate and medroxyprogesterone acetate in different age groups of postmenopausal women

Asko Järvinen, Petri Kainulainen, Minna Nissilä et al. · Maturitas · 2003 · 15 citations

, , +15

1–3 of 3